HOME > About us > Medicines

	We aspire to be the Leading Company in the Japanese pharmaceutical industry.
	AstraZeneca delivers medicines that meet the needs of patients and health care professionals by providing information based on evidence and by using our global network in R&D, manufacturing and supply, and information collection. The sales breakdown by therapeutic area of AstraZeneca in Japan is as flows: Prostate Cancer accounts for 33%, Breast Cancer 12%, Lung Cancer 7%, Anesthesia 6%, Cardiovascular 20%, Gastrointestinal 17%, Respiratory 4%, CNS, 1%.

Key Products of AstraZeneca in Japan

■Tenormin Treatment for hypertension, angina, arrhythmia ■Seloken Treatment for hypertension, angina, arrhythmia ■Zestril Treatment for hypertension, angina, arrhythmia ■Crestor Treatment for hypercholesterolaemia, etc.

■Accolate Treatment for bronchial asthma ■Pulmicort 　Turbuhaler Treatment for bronchial asthma ■Pulmicort 　Respules Treatment for bronchial asthma ■Symbicort 　 Turbuhaler Treatment for bronchial asthma

■Omepral Treatment for peptic ulcers, etc.

■Zomig Treatment for migraine

■Casodex Treatment for prostate cancer ■Zoladex Treatment for prostate cancer, premenopausal breast cancer ■Nolvadex Treatment for breast cancer ■Arimidex Treatment for postmenopausal breast cancer ■Iressa Treatment for inoperable and recurrent non-small cell lung cancer

■Xylocaine Local anaesthesia ■Anapaine Local anaesthesia ■Diprivan General anaesthesia